SB 1102 Arizona Senate · 57th Legislature - First Regular Session

pharmacy benefits; prescribing; exemption

SB 1102 prevents pharmacy benefit managers (PBMs) from suddenly removing a prescription drug from coverage for patients already taking it, unless the drug is discontinued. It requires PBMs to provide 60 days' notice before changing drug coverage and establishes a streamlined process for doctors to request continued access to excluded medications. Patients must obtain approval through this exception process to keep using a drug that was previously covered but is now excluded from the formulary. The law applies to all health insurers and PBMs in Arizona, ensuring continuity of care for those on established prescriptions.
Bill status signed all 5 stages cleared
Introduction
Jan 2025
Committee Review
Mar 2025
Senate Passage
Feb 2025
House Passage
Mar 2025
Signed into Law
Mar 2025
Introduced Jan 16, 2025 Signed Mar 25, 2025
Maddy AI version diff · 2 comparisons

What changed between versions

Senate Engrossed Version Chaptered Version · 7 edits
MODERATE
This bill establishes new protections for prescription drug coverage by pharmacy benefit managers (PBMs) in Arizona, requiring them to maintain coverage for specific drugs once approved and providing clear processes for formulary exceptions. The changes ensure patients can continue on their current medications without arbitrary coverage changes and create faster response times for exception requests.
Scope change
The bill applies to contracts, policies, or evidences of coverage entered into, amended, extended, or renewed on or after December 31, 2025, and only applies to pharmacy benefit managers subject to section 20-3333.
REQUIREMENT

PBMs cannot limit or exclude coverage for prescription drugs that were previously approved for a covered individual, as long as the individual remains enrolled with the same health care insurer.

PBMs must provide at least 60 days' notice before making formulary changes that affect covered individuals, including information about how to request continued use of nonformulary drugs.

PBMs must respond to formulary exception requests within 72 hours, or 24 hours for expedited reviews in exigent circumstances.

New criteria for automatic approval of formulary exceptions when a patient has been previously approved for the same nonformulary drug under the same plan.

Written denials of formulary exceptions must include medical or pharmacological reasons and be sent to the patient's treating health care provider.

DEFINITION

New definition of 'limit or exclude coverage' to include increasing cost sharing and requiring additional prior authorization based solely on formulary tier changes.

Expanded definition of when a drug can be removed from a formulary to include situations where the manufacturer notifies the FDA of discontinuation.

Floor votes · Senate Feb 11, 2025 · House Mar 18, 2025

How they voted

260
Passed · 4 other
Total votes 30
Feb 11, 2025
D Democratic13
9 Yea 4
69% Yea
R Republican17
17 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
15
Key actions
7
Committee
1
Amendments
2
Mar 25, 2025
Signed into law
Signed by Governor
executive
Mar 18, 2025
Lower · Passed
PASSED
lower
Mar 13, 2025
Lower · Passed
DP
lower
Mar 3, 2025
Lower · Passed
DP
lower
Feb 11, 2025
Upper · Passed
PASSED
upper
Feb 10, 2025
Upper · Passed
DPA
upper
Jan 29, 2025
Upper · Passed
DPA
upper
1 primary · 6 co-sponsors

Sponsors